Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18539055

Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus pneumoniae

Author
ANDERSON, R1 ; STEEL, H. C1 ; COCKERAN, R1 ; SMITH, A. M2 ; VON GOTTBERG, A2 ; DE GOUVEIA, L2 ; BRINK, A3 ; KLUGMAN, K. P2 4 ; MITCHELL, T. J5 ; FELDMAN, C6
[1] Medical Research Council Unit for Inflammation and Immunity, Department of Immunology, Faculty of Health Sciences, University of Pretoria and Tshwane Academic Division of the National Health Laboratory Service, Pretoria, South Africa
[2] MRC/NICD/WITS Respiratory and Meningeal Pathogens Research Unit, National Institute for Communicable Diseases, Johannesburg, South Africa
[3] Ampath Laboratories, Johannesburg, South Africa
[4] Hubert Department of Global Health, Rollins School of Public Health, and Division of Infectious Diseases, School of Medicine, Emory University, Atlanta, GA, United States
[5] Division of Infection and Immunity, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom
[6] Division of Pulmonology, Department of Medicine, Johannesburg Hospital and University of the Witwatersrand, Johannesburg, South Africa
Source

Journal of antimicrobial chemotherapy (Print). 2007, Vol 59, Num 2, pp 224-229, 6 p ; ref : 26 ref

CODEN
JACHDX
ISSN
0305-7453
Scientific domain
Microbiology, infectious diseases; Pharmacology drugs
Publisher
Oxford University Press, Oxford
Publication country
United Kingdom
Document type
Article
Language
English
Author keyword
Streptococcus pneumoniae community-acquired pneumonia macrolide resistance p-lactam antibiotics
Keyword (fr)
Antibactérien Antibiotique Association médicamenteuse Ceftriaxone Clarithromycine Cytolysine Infection communautaire Lactame Macrolide Pneumococcie Pneumonie Résistance Souche Streptococcus pneumoniae Pneumolysine Appareil respiratoire pathologie Bactérie Bactériose Céphalosporine dérivé Infection Inhibiteur synthèse protéique Micrococcales Poumon pathologie Streptococcaceae Streptococcie β-Lactamines
Keyword (en)
Antibacterial agent Antibiotic Drug combination Ceftriaxone Clarithromycin Cytolysin Community acquired infection Lactam Macrolide Pneumococcal infection Pneumonia Resistance Strain Streptococcus pneumoniae Pneumolysin Respiratory disease Bacteria Bacteriosis Cephalosporin derivatives Infection Protein synthesis inhibitor Micrococcales Lung disease Streptococcaceae Streptococcal infection β-Lactams
Keyword (es)
Antibacteriano Antibiótico Asociación medicamentosa Ceftriaxona Claritromicina Citolisina Infección comunitaria Lactamo Macrólido Neumococia Neumonía Resistencia Cepa Streptococcus pneumoniae Aparato respiratorio patología Bacteria Bacteriosis Cefalosporina derivado Infección Inhibidor síntesis proteica Micrococcales Pulmón patología Streptococcaceae Estreptococia β-Lactams
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02S Antibiotics. Antiinfectious agents. Antiparasitic agents

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B05 Infectious diseases / 002B05B Bacterial diseases / 002B05B02 Human bacterial diseases / 002B05B02N Staphylococcal infections, streptococcal infections, pneumococcal infections

Discipline
Infectious pathology Pharmacological treatments
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
18539055

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web